Immunovant Inc (IMVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2024 | 03-2023 | 03-2022 | 03-2021 | 03-2020 | |
| Operating Expenses | 282,709 | 218,276 | 156,033 | 108,117 | 66,078 |
| Operating Income | -282,709 | -218,276 | -156,033 | -108,117 | -66,078 |
| Interest Expense | 0 | 0 | 0 | 0 | 625 |
| Other Income | 23,940 | 7,325 | -781 | 328 | 412 |
| Pre-tax Income | -258,769 | -210,951 | -156,814 | -107,789 | -66,291 |
| Income Tax | 567 | 9 | -84 | -358 | 97 |
| Net Income Continuous | -259,336 | -210,960 | -156,730 | -107,431 | -66,388 |
| Net Income | $-259,336 | $-210,960 | $-156,730 | $-107,431 | $-66,388 |
| EPS Basic Total Ops | -1.88 | -1.71 | -1.43 | -1.22 | -1.54 |
| EPS Basic Continuous Ops | -1.88 | -1.71 | -1.43 | -1.22 | -1.54 |
| EPS Diluted Total Ops | -1.88 | -1.71 | -1.43 | -1.22 | -1.54 |
| EPS Diluted Continuous Ops | -1.88 | -1.71 | -1.43 | -1.22 | -1.54 |
| EPS Diluted Before Non-Recurring Items | -1.78 | -1.71 | -1.43 | -1.22 | -1.54 |
| EBITDA(a) | $-282,478 | $-218,083 | $-155,907 | $-108,052 | $-66,057 |